Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:S121-S129
doi: 10.1161/CIRCULATIONAHA.107.759480
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Bogt, K. E.A.
Right arrow Articles by Wu, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Bogt, K. E.A.
Right arrow Articles by Wu, J. C.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Cell biology/structural biology
Right arrow Imaging
Right arrow Transplantation
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Circulation. 2008;118:S121-S129.)
© 2008 American Heart Association, Inc.


Cell Transplantation and Tissue Regeneration

Comparison of Different Adult Stem Cell Types for Treatment of Myocardial Ischemia

Koen E.A. van der Bogt, MD; Ahmad Y. Sheikh, MD; Sonja Schrepfer, MD, PhD; Grant Hoyt, BS; Feng Cao, MD, PhD; Katherine J. Ransohoff; Rutger-Jan Swijnenburg, MD; Jeremy Pearl, BS; Andrew Lee, BS; Michael Fischbein, MD; Christopher H. Contag, PhD; Robert C. Robbins, MD; Joseph C. Wu, MD, PhD

From the Laboratory of Cardiothoracic Transplantation (K.E.A.v.d.B., A.Y.S., S.S., G.H., K.J.R., R.J.S., J.P., M.F., R.C.R.), the Molecular Imaging Program at Stanford (MIPS) (K.E.A.v.d.B., F.C., R.J.S., A.L., J.C.W.), the Department of Pediatrics (C.H.C.), and the Department of Medicine, Division of Cardiology (J.C.W.), Stanford University School of Medicine, Stanford, Calif; and the Department of Surgery (K.E.A.v.d.B., R.J.S.), Leiden University Medical Center, Leiden, The Netherlands.

Correspondence to Joseph C. Wu, MD, PhD, 300 Pasteur Drive, Edwards Building R-354, Stanford, CA 94305-5324. E-mail joewu{at}stanford.edu

Background— A comparative analysis of the efficacy of different cell candidates for the treatment of heart disease remains to be described. This study is designed to evaluate the therapeutic efficacy of 4 cell types in a murine model of myocardial infarction.

Methods and Results— Bone marrow mononuclear cells (MN), mesenchymal stem cells (MSC), skeletal myoblasts (SkMb), and fibroblasts (Fibro) expressing firefly luciferase (Fluc) and green fluorescence protein (GFP) were characterized by flow cytometry, bioluminescence imaging (BLI), and luminometry. Female FVB mice (n=70) underwent LAD ligation and intramyocardially received one cell type (5x105) or PBS. Cell survival was measured by BLI and by TaqMan PCR. Cardiac function was assessed by echocardiography and invasive hemodynamic measurements. Fluc expression correlated with cell number in all groups (r2>0.93). In vivo BLI revealed acute donor cell death of MSC, SkMb, and Fibro within 3 weeks after transplantation. By contrast, cardiac signals were still present after 6 weeks in the MN group, as confirmed by TaqMan PCR (P<0.01). Echocardiography showed significant preservation of fractional shortening in the MN group compared to controls (P<0.05). Measurements of left ventricular end-systolic/diastolic volumes revealed that the least amount of ventricular dilatation occurred in the MN group (P<0.05). Histology confirmed the presence of MN, although there was no evidence of transdifferentiation by donor MN into cardiomyocytes.

Conclusions— This is the first study to show that compared to MSC, SkMB, and Fibro, MN exhibit a more favorable survival pattern, which translates into a more robust preservation of cardiac function.


Key Words: myocardial infarction • molecular imaging • bone marrow stem cells • mesenchymal stem cells • skeletal myoblasts




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. M. Smits, L. W. van Laake, K. den Ouden, C. Schreurs, K. Szuhai, C. J. van Echteld, C. L. Mummery, P. A. Doevendans, and M.-J. Goumans
Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium
Cardiovasc Res, August 1, 2009; 83(3): 527 - 535.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. L. Kraitchman and J. W.M. Bulte
In Vivo Imaging of Stem Cells and Beta Cells Using Direct Cell Labeling and Reporter Gene Methods
Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1025 - 1030.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Z. Li, A. Lee, M. Huang, H. Chun, J. Chung, P. Chu, G. Hoyt, P. Yang, J. Rosenberg, R. C. Robbins, et al.
Imaging survival and function of transplanted cardiac resident stem cells.
J. Am. Coll. Cardiol., April 7, 2009; 53(14): 1229 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
M. Nahrendorf, D. E. Sosnovik, B. A. French, F. K. Swirski, F. Bengel, M. M. Sadeghi, J. R. Lindner, J. C. Wu, D. L. Kraitchman, Z. A. Fayad, et al.
Multimodality Cardiovascular Molecular Imaging, Part II
Circ Cardiovasc Imaging, January 1, 2009; 2(1): 56 - 70.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. C. Wu
Molecular Imaging: Antidote to Cardiac Stem Cell Controversy
J. Am. Coll. Cardiol., November 11, 2008; 52(20): 1661 - 1664.
[Full Text] [PDF]